BioCentury
ARTICLE | Clinical News

Inovio preclinical data

September 2, 2013 7:00 AM UTC

In mice and non-human primates, Inovio's SynCon malaria DNA vaccine produced "robust and sustained" antibody responses to all 4 malaria antigens tested, according to the company. The vaccine also indu...